Lonza Amaxa 4D-Nucleofector system

Monday, 02 August, 2010 | Supplied by: Lonza Australia Pty Ltd

The Amaxa Nucleofector technology is claimed to be the first efficient non-viral transfection method for primary cells and hard-to-transfect cell lines.

With a new platform, the 4D-Nucleofector system enables nucleofection of cells in several formats, combined with good performance and convenience.

Its features include: transfection of variable cell numbers with same conditions; choice of throughputs from 1 to 16 wells in just 10 s; nucleofection of adherent cells for functional assays at various cellular stages.

The modular system will accommodate upcoming transfection challenges and a current transfection protocol database is available with 690 cells listed, which is continuously updated.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

BioGX Xfree COVID-19 Direct RT-PCR test

The Xfree COVID-19 Direct RT-PCR test is a complete test in a single vial, lyophilised...

Bio-Rad Laboratories CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems

Bio-Rad Laboratories' CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems are suitable for...

PCR Biosystems NGSBIO Library Quant Kit for Illumina

The kit contains all the components necessary for sensitive quantification of DNA libraries prior...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd